On February 25, 2023, Elevance Health (ELV), formerly known as Anthem Inc (ANTM), will raise its quarterly dividend by 15.6% to $1.48 quarterly per share. This marks 12 straight years of increased dividends by the health benefits company. The next ex-dividend date for ELV is March 9, 2023 and the dividend yield is 1.2% at a stock price of $492. In 2022 the company names Anthem hiked the dividend by 13.3%.
|ELV Dividend history & statistics|
|Company name||Elevance Health|
|Dividend paid since||2011|
|Track record (years increased)||12|
|Payment Frequency||Quarterly dividend|
|Dividend growth: 5 year average||14.6%|
|Next dividend per share||$1.480|
|Annual dividend per share||$5.92|
|YTD Total Return*||-4.0%|
|Next ex-dividend date||March 9, 2023|
|Next payment date||March 24, 2023|
|Market cap (in $B)*||117.63|
|Total dividend (in $B)||1.41|
|© www.dividendhike.com||*As of January 27, 2023|
On January 24, 2023, the Audit Committee of the Company's Board of Directors declared a first quarter 2023 dividend to shareholders of $1.48 per share, an increase of 16 percent from the quarterly dividend payment in the fourth quarter. On an annualized basis, the new quarterly dividend equates to $5.92 per share. The first quarter dividend is payable on March 24, 2023, to shareholders of record at the close of business on March 10, 2023.
Elevance Health, the former Anthem, Inc., is a health benefits company. The company offers managed care plans to large and small employer, individual, Medicaid and Medicare markets. Elevance Health supports consumers, families, and communities across the entire care journey – connecting them to the care, support, and resources they need to lead healthier lives. Elevance Health’s companies serve millions of people through a diverse portfolio of industry-leading medical, digital, pharmacy, behavioral, clinical, and complex care solutions. Elevance Health has four reportable segments: Commercial & Specialty Business (comprised of Individual, Group risk-based, Group fee-based, and BlueCard businesses); Government Business (comprised of the Medicaid, Medicare, and Federal Health Products & Services businesses); CarelonRx (formerly IngenioRx); and Other.